Health

Novartis meningitis vaccine used at 2nd US campus

GENEVA (AP) — Swiss drug maker Novartis says a second U.S. university is using its new vaccine against meningitis B.

Novartis said Monday that the vaccine, Bexsero, is being used at the University of California Santa Barbara until March 7 to help protect 20,000 students and staff after an outbreak. The vaccine shot for the B strain of the meningitis bacteria is approved for use in Europe, Australia and Canada, but not yet for general use in the United States.

But the U.S. Food and Drug Administration has now approved the use of Bexsero twice in response to outbreaks at U.S. college campuses. It is the first vaccine against the B strain of meningitis. Princeton University says almost 5,300 people got the vaccine last year in an effort to halt an outbreak there.

Related Headlines

  • Gay men concerned after LA meningitis deaths

    In the heart of this close-knit gay community, Luke Martel reflects the feelings of many when it comes to a strain of meningitis that has killed three gay men this year in Los ... 

  • Sue McFarren

    Measles outbreak complicates 2 big Amish events

    Visitors from around the world to two upcoming events in the state's Amish country could come away with more than they bargained for, health officials fear — a case of measles ... 

  • Trial: dengue shot offers some protection

    The most advanced vaccine for dengue only offers modest protection but could still help millions of people avoid the devastating effects of the disease known as "breakbone ... 

  • AP WAS THERE: Probable cause of AIDS found

    EDITOR'S NOTE: In 1981, the U.S. Centers for Disease Control and Prevention reported the first cases of a rare pneumonia that had sickened five Los Angeles gay men. The AIDS ... 

Find your future job here